North India is about to witness a healthcare manufacturing revolution. The Yamuna Expressway Industrial Development Authority (YEIDA) has decided to develop a Japanese medical device manufacturing cluster near Noida International airport, marking a significant milestone for India’s “Make in India” initiative. This strategic partnership between YEIDA and Medical Excellence Japan (MEJ) promises to transform the region into a global hub for cutting-edge medical technology.
Table of Contents
YEIDA Project Overview at a Glance
| Aspect | Details |
|---|---|
| Location | Sector 28, YEIDA (Near Noida International Airport) |
| Total Area | 350 acres |
| Partner | Medical Excellence Japan (MEJ) |
| Initial Companies | 7+ Japanese medical device firms |
| Project Cost | ₹440 crore |
| Expected Completion | January 2026 |
| Central Govt. Grant | ₹100 crore |
A Strategic Partnership That Changes Everything
During a YEIDA office visit, MEJ officials met with YEIDA chief executive officer RK Singh and officer on special duty Shailendra Bhatia to finalize details of an MoU focused on collaboration in the medical devices sector. The memorandum of understanding will be signed during an upcoming Japanese delegation visit, paving the way for at least seven leading Japanese firms to establish manufacturing and R&D units.
“This partnership with MEJ is a game-changer for the Medical Devices Park and the ‘Make in India’ initiative. It will accelerate the creation of a sophisticated healthcare ecosystem, driving innovation, and positioning us as a key global manufacturing location,” said YEIDA CEO RK Singh.
What Makes This Cluster Special?
Technology Transfer: The partnership will enable the transfer of cutting-edge technology and know-how from Japanese firms to Indian companies, bridging the technological gap in medical device manufacturing.
Export Opportunities: The collaboration will create new export opportunities for products manufactured by Indian companies at the park, targeting the specialized Japanese healthcare market.
Strategic Location: Positioned just 3 km from the upcoming Noida International Airport, the park offers unmatched connectivity for global logistics and supply chain management.
The Bigger Picture: North India’s First Medical Device Park
This Japanese cluster is part of North India’s first dedicated medical device park, spread over 350 acres. YEIDA has been nominated as the State Implementation Agency by the Department of Pharmaceuticals, Ministry of Chemical & Fertilizers, Government of India, underlining the project’s national importance.
The park will manufacture diverse medical equipment including cancer care devices, radiology imaging systems, cardio-respiratory equipment, renal care devices, and implantable electronics—addressing India’s heavy reliance on imported medical technology.
Investor-Friendly Incentives
The Government of Uttar Pradesh offers attractive incentives including reimbursement of up to 7.5% interest on loans for plant and machinery, 70% reimbursement of net SGST for 10 years, special incentives for air cargo handling charges, and 50% EPF reimbursement for units providing employment to 100 or more workers.
Impact on Healthcare and Economy
For patients, this means access to affordable, high-quality medical devices manufactured domestically. For the economy, it translates to thousands of jobs, reduced import dependency, and positioning India as a global medical device manufacturing powerhouse.
The timing couldn’t be better. India’s healthcare market is booming, and the government’s push for self-reliance in critical sectors makes this Japanese collaboration a strategic masterstroke. The integration of Japanese precision engineering with India’s manufacturing prowess creates a win-win scenario.
Looking Ahead
With infrastructure development nearly complete and the central government directing completion by January 2026, the park is on track to become operational soon. The Japanese delegation’s upcoming visit will finalize investment commitments and explore co-manufacturing opportunities with Indian companies.
For Uttar Pradesh, this isn’t just about manufacturing medical devices—it’s about positioning the state as India’s healthcare innovation capital. The ripple effects will benefit related industries, create a skilled workforce, and attract further international investments.
Stay Connected
Want more updates on India’s infrastructure boom and technology developments? Explore our coverage on business developments and innovation trends.
Frequently Asked Questions
Q1: What types of medical devices will be manufactured at this Japanese cluster?
The park will produce a wide range of advanced medical equipment including cancer care and radiotherapy devices, radiology and imaging systems (X-ray, nuclear imaging), cardio-respiratory and anesthetic devices (ICU ventilators, anesthesia workstations), renal care equipment (hemodialysis kits), implantable electronics for spinal and coronary applications, oxygen concentrators, endoscopic tools, chemotherapy systems, and intraocular lenses. This comprehensive manufacturing base aims to reduce India’s dependence on imported medical technology.
